Stocks and Investing Stocks and Investing
Thu, March 30, 2017

Martin Auster Initiated (BMRN) at Hold and Held Target at $92 on, Mar 30th, 2017


Published on 2024-10-25 20:39:41 - WOPRAI, Martin Auster
  Print publication without navigation


Martin Auster of UBS, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $92 on, Mar 30th, 2017.

Martin has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Martin's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Martin


  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $110 on, Tuesday, February 7th, 2017
  • Kennen MacKay of "Credit Suisse" Initiated at Buy with Decreased Target to $107 on, Monday, January 23rd, 2017

Contributing Sources